Skip to main content
SpringerLink
Log in

HIV–HBV and HIV–HCV Coinfection and Liver Cancer Development

  • Chapter
Aids-Associated Viral Oncogenesis

Part of the book series: Cancer Treatment and Research ((CTAR,volume 133))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thomas, D. L. 2006. Growing importance of liver disease in HIV-infected persons. Hepatology 43(2 Suppl 1):S221–9.

    Article  PubMed  Google Scholar 

  2. Cacoub, P., L. Geffray, E. Rosenthal, et al. 2001. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 32(8):1207–14.

    Article  PubMed  CAS  Google Scholar 

  3. Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med 350(11):1118–29.

    Article  PubMed  CAS  Google Scholar 

  4. Yim, H. J., and A. S. Lok. 2006. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173–81.

    Article  PubMed  CAS  Google Scholar 

  5. Wright, T. L. 2006. Introduction to chronic hepatitis B infection. Am J Gastroenterol 101(Suppl 1):S1–6.

    Article  PubMed  Google Scholar 

  6. Lindenbach, B. D., and C. M. Rice, Unravelling hepatitis C virus replication from genome to function. Nature, 2005. 436(7053): p. 933–8.

    Article  PubMed  CAS  Google Scholar 

  7. Chen, S. L., and T. R. Morgan. 2006. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3(2):47–52.

    PubMed  Google Scholar 

  8. Seeff, L. B. 1999. Natural history of hepatitis C. Am J Med 107(6B):10S–15S.

    Article  PubMed  CAS  Google Scholar 

  9. Park, J. S., N. Saraf, and D. T. Dieterich. 2006. HBV plus HCV, HCV plus HIV, HBV plus HIV. Curr Gastroenterol Rep 8(1):67–74.

    Article  PubMed  Google Scholar 

  10. Alter, M. J. 2006. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44(1 Suppl):S6–9.

    Article  PubMed  Google Scholar 

  11. Lascar, R. M., A. R. Lopes, R. J. Gilson, et al. 2005. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J Infect Dis 191(7):1169–79.

    Article  PubMed  CAS  Google Scholar 

  12. Yeo, W., K. C. Lam, B. Zee, et al. 2004. Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy. Ann Oncol 15(11):1661–6.

    Article  PubMed  CAS  Google Scholar 

  13. Sterling, R. K., and M. S. Sulkowski. 2004. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection. Semin Liver Dis 24(Suppl 2):61–8.

    Article  PubMed  Google Scholar 

  14. Liu, Z., and J. Hou. 2006. Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci 3(2):57–62.

    PubMed  Google Scholar 

  15. Chemin, I., and C. Trepo. 2005. Clinical impact of occult HBV infections. J Clin Virol 34(Suppl 1):S15–21.

    Article  PubMed  Google Scholar 

  16. Tamori, A., S. Nishiguchi, S. Shiomi, et al. 2005. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Am J Gastroenterol 100(8):1748–53.

    Article  PubMed  CAS  Google Scholar 

  17. Michalak, T. I., P. M. Mulrooney, and C. S. Coffin. 2004. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J Virol 78(4):1730–8.

    Article  PubMed  CAS  Google Scholar 

  18. Pal, S., D. G. Sullivan, S. Kim, et al. 2006. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: Implications of HCV lymphotropism. Gastroenterology 130(4):1107–16.

    Article  PubMed  Google Scholar 

  19. Brechot, C. 2004. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: Old and new paradigms. Gastroenterology 127(5 Suppl 1):S56–61.

    Article  PubMed  CAS  Google Scholar 

  20. Branda, M., and J. R. Wands. 2006. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology 43(5):891–902.

    Article  PubMed  CAS  Google Scholar 

  21. Thorgeirsson, S. S., and J. W. Grisham. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31(4):339–46.

    Article  PubMed  CAS  Google Scholar 

  22. Fattovich, G., T. Stroffolini, I. Zagni, et al. 2004. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127(5 Suppl 1):S35–50.

    Article  PubMed  Google Scholar 

  23. Chen, J. G., J. Zhu, D. M. Parkin, et al. 2006. Trends in the incidence of cancer in Qidong, China, 1978–2002. Int J Cancer.

    Google Scholar 

  24. Davila, J. A., R. O. Morgan, Y. Shaib, et al. 2004. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study. Gastroenterology 127(5):1372–80.

    Article  PubMed  Google Scholar 

  25. El-Serag, H. B. 2004. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 127(5 Suppl 1):S27–34.

    Article  PubMed  Google Scholar 

  26. Parkin, D. M. 2006. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118(12):3030–44.

    Article  PubMed  CAS  Google Scholar 

  27. Tradati, F., M. Colombo, P. M. Mannucci, et al. 1998. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 91(4):1173–7.

    PubMed  CAS  Google Scholar 

  28. Liang, T. J., and T. Heller. 2004. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S62–71.

    Article  PubMed  CAS  Google Scholar 

  29. Block, T. M., A. S. Mehta, C. J. Fimmel, et al. 2003. Molecular viral oncology of hepatocellular carcinoma. Oncogene 22(33):5093–107.

    Article  PubMed  CAS  Google Scholar 

  30. Anzola, M. 2004. Hepatocellular carcinoma: Role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 11(5):383–93.

    Article  PubMed  CAS  Google Scholar 

  31. Cougot, D., C. Neuveut, and M. A. Buendia. 2005. HBV induced carcinogenesis. J Clin Virol 34(Suppl 1): S75–8.

    Article  PubMed  CAS  Google Scholar 

  32. Murakami, Y., K. Saigo, H. Takashima, et al. 2005. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54(8):1162–8.

    Article  PubMed  CAS  Google Scholar 

  33. Minami, M., Y. Daimon, K. Mori, et al. 2005. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene 24(27):4340–8.

    Article  PubMed  CAS  Google Scholar 

  34. Hsu, T., T. Moroy, J. Etiemble, et al. 1988. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55:627–35.

    Article  PubMed  CAS  Google Scholar 

  35. Moroy, T., A. Marchio, J. Etiemble, et al. 1986. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 324:276–9.

    Article  PubMed  CAS  Google Scholar 

  36. Fourel, G., C. Trepo, L. Bougueleret, et al. 1990. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347(6290):294–8.

    Article  PubMed  CAS  Google Scholar 

  37. Dejean, A., L. Bougueleret, K. H. Grzeschik, et al. 1986. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 322:70–2.

    Article  PubMed  CAS  Google Scholar 

  38. Wang, J., X. Chenivesse, B. Henglein, et al. 1990. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343(6258):555–7.

    Article  PubMed  CAS  Google Scholar 

  39. Benhamou, Y., M. Bochet, V. Di Martino, et al. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30(4):1054–8.

    Article  PubMed  CAS  Google Scholar 

  40. Colin, J. F., D. Cazals-Hatem, M. A. Loriot, et al. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29(4):1306–10.

    Article  PubMed  CAS  Google Scholar 

  41. Weinig, M., J. G. Hakim, I. Gudza, et al. 1997. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: A pilot study. Trans R Soc Trop Med Hyg 91(5):570–2.

    Article  PubMed  CAS  Google Scholar 

  42. Tswana, S. A., and S. R. Moyo. 1992. The interrelationship between HBV-markers and HIV antibodies in patients with hepatocellular carcinoma. J Med Virol 37(3):161–4.

    Article  PubMed  CAS  Google Scholar 

  43. Sherman, M. 2006. Optimizing management strategies in special patient populations. Am J Gastroenterol 101(Suppl 1):S26–31.

    Article  PubMed  Google Scholar 

  44. Puoti, M., R. Bruno, V. Soriano, et al. 2004. Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome. AIDS 18(17):2285–93.

    Article  PubMed  Google Scholar 

  45. Kramer, J. R., T. P. Giordano, J. Souchek, et al. 2005. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 100(1):56–63.

    Article  PubMed  Google Scholar 

  46. Giordano, T. P., J. R. Kramer, J. Souchek, et al. 2004. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: A cohort study, 1992–2001. Arch Intern Med 164(21):2349–54.

    Article  PubMed  Google Scholar 

  47. Garcia-Samaniego, J., M. Rodriguez, J. Berenguer, et al. 2001. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 96(1):179–83.

    PubMed  CAS  Google Scholar 

  48. Bruno, R., M. Puoti, P. Sacchi, et al. 2006. Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. J Hepatol 44(1 Suppl):S146–50.

    Article  PubMed  CAS  Google Scholar 

  49. Smukler, A. J., and L. Ratner. 2002. Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients. Curr Opin Oncol 14(5):538–42.

    Article  PubMed  Google Scholar 

  50. Hyun, C. B., and W. J. Coyle. 2004. Hepatocellular carcinoma in a patient with human immunodeficiency virus and hepatitis B virus coinfection: An emerging problem? South Med J 97(4):401–6.

    Article  PubMed  Google Scholar 

  51. Tanaka, T., A. Imamura, G. Masuda, et al. 1996. A case of hepatocellular carcinoma in HIV-infected patient. Hepatogastroenterology 43(10):1067–72.

    PubMed  CAS  Google Scholar 

  52. Chen, C. J., H. I. Yang, J. Su, et al. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295(1):65–73.

    Article  PubMed  CAS  Google Scholar 

  53. Ohata, K., K. Hamasaki, K. Toriyama, et al. 2004. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 19(6):670–5.

    Article  PubMed  Google Scholar 

  54. Hu, J., and D. Nguyen. 2004. Therapy for chronic hepatitis B: The earlier, the better? Trends Microbiol 12(10):431–3.

    Article  PubMed  CAS  Google Scholar 

  55. van Zonneveld, M., P. Honkoop, B. E. Hansen, et al. 2004. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology 39(3):804–10.

    Article  PubMed  Google Scholar 

  56. Akuta, N., F. Suzuki, Y. Suzuki, et al. 2005. Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: An 8-year follow-up study. J Med Virol 75(4):491–8.

    Article  PubMed  CAS  Google Scholar 

  57. Liaw, Y. F., J. J. Sung, W. C. Chow, et al. 2004. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351(15):1521–31.

    Article  PubMed  CAS  Google Scholar 

  58. Matsumoto, A., E. Tanaka, A. Rokuhara, et al. 2005. Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients. Hepatol Res.

    Google Scholar 

  59. Shindo, M., K. Hamada, Y. Oda, et al. 2001. Long-term follow-up study of sustained biochemical responders with interferon therapy. Hepatology 33(5):1299–302.

    Article  PubMed  CAS  Google Scholar 

  60. Tsuda, N., N. Yuki, K. Mochizuki, et al. 2004. Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy. J Med Virol 74(3):406–13.

    Article  PubMed  CAS  Google Scholar 

  61. Meuleman, P., L. Libbrecht, S. Wieland, et al. 2006. Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus. J Virol 80(6):2797–807.

    Article  PubMed  CAS  Google Scholar 

  62. Yoon, E. J., and K. Q. Hu. 2006. Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci 3(2):53–6.

    PubMed  Google Scholar 

  63. Gaslightwala, I., and E. J. Bini. 2006. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection. J Hepatol.

    Google Scholar 

  64. Altavilla, G., A. Caputo, M. Lanfredi, et al. 2000. Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol 157(4):1081–9.

    PubMed  CAS  Google Scholar 

  65. Pol, S., P. Lebray, and A. Vallet-Pichard. 2004. HIV infection and hepatic enzyme abnormalities: Intricacies of the pathogenic mechanisms. Clin Infect Dis 38(Suppl 2):S65–72.

    Article  PubMed  CAS  Google Scholar 

  66. Stapleton, J. T., C. F. Williams, and J. Xiang. 2004. GB virus type C: A beneficial infection? J Clin Microbiol 42(9):3915–9.

    Article  PubMed  Google Scholar 

  67. Berzsenyi, M. D., D. S. Bowden, and S. K. Roberts. 2005. GB virus C: Insights into co-infection. J Clin Virol 33(4):257–66.

    Article  PubMed  CAS  Google Scholar 

  68. Xiang, J., S. Wunschmann, D. J. Diekema, et al. 2001. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345(10):707–14.

    Article  PubMed  CAS  Google Scholar 

  69. Tillmann, H. L., H. Heiken, A. Knapik-Botor, et al. 2001. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345(10):715–24.

    Article  PubMed  CAS  Google Scholar 

  70. Xiang, J., S. L. George, S. Wunschmann, et al. 2004. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 363(9426):2040–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, PA

    Jianming Hu

  2. Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, PA

    Laurie Ludgate

Authors
  1. Jianming Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laurie Ludgate
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

C. Meyers

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hu, J., Ludgate, L. (2007). HIV–HBV and HIV–HCV Coinfection and Liver Cancer Development. In: Meyers, C. (eds) Aids-Associated Viral Oncogenesis. Cancer Treatment and Research, vol 133. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-46816-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-46816-7_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-46804-4

  • Online ISBN: 978-0-387-46816-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation